Launch of Generic Nitrolingual® Pump Spray
On September 20, 2013, Perrigo received final FDA approval and launched the generic equivalent of Arbor’s brand product Nitrolingual® Pump Spray. Perrigo is exclusive in the market, with 180 day exclusivity on this product. Estimated U.S. annual brand sales for this product are $30M.
Nitrolingual® Pump Spray (nitroglycerin lingual spray) is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.